Singapore, Singapore
DotBio's proprietary DotBody technology platform is based on the concept of modular design. By prefabricating antibody modules with specific functions, DotBio is able to combine them on demand to build multi-functional antibodies. This high throughput process allows DotBio to generate bi- and tri- specific antibodies, antibody-drug conjugates (ADCs) and intracellular antibodies in a matter of months.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for DotBio on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
